D.E. Shaw & Co
RUBY

D.E. Shaw & Co’s Rubius Therapeutics, Inc RUBY Stock Holding History

D.E. Shaw & Co’s Portfolio RUBY Stock Details RUBY Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
2022
Q2 		$100K Buy
2022
Q1 		$302K Sell
2021
Q4 		$890K Sell
2021
Q3 		$1.84M Sell
2021
Q2 		$3.16M Sell
2021
Q1 		$4.47M Buy
2020
Q4 		$1.22M Buy
2020
Q3 		$187K Buy
2020
Q2 		$104K Buy